Seres (MCRB) Stock: Here’s What You Need To Know

Seres Therapeutics (NASDAQ:MCRB) On Friday, Seres Therapeutics stock plummeted by 70% after the company reported that it had failed mid-stage trial in patients with Clostridium difficile infection or C. diff. The company has a big pipeline, but the problem is that the study that failed was the lead drug candidate. Thus, the reason why the … Read more

Biotech Stock News (AMGN) (RGLS) (BIIB) (RVNC) (AGN)

Amgen, Inc. (NASDAQ:AMGN) On October 28, 2015 Amgen had announced that it had received FDA approval for its skin cancer drug known as IMLYGIC. This drug is an injection type drug that helps boost the immune system to fight off and kill cancerous skin cells. This therapy only treats Melanoma — skin cancer– but does … Read more

Biotech Stock News: (GALE) (AMGN) (ARIA) (BXLT)

Galena Biopharma (NASDAQ:GALE) On Monday August 24, 2015 Shares of Galena Biopharma were able to close the day up 11% after announcing an update for its phase 3 trial known as the “PRESENT” trial. The company announced that the independent data monitoring committee — IDMC — concluded that it would be able to reduce the … Read more

Pacific Safety Products’ Unknown Turnaround Offers Big Upside

Article highlights: – Pacific Safety Products is a vastly undervalued micro-cap operating in the security equipment industry. – Investors never heard of this stock. You won’t find any coverage on investment platforms like this one and no mentions on social media, Yahoo message boards or Investorshub. – This company sports a sound balance sheet, makes … Read more